Develops custom adhesive formulations for individual factory conditions, then turns those into die-cut labels and tags.
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 0
- ScaleMarket cap is above the global median
Develops custom adhesive formulations for individual factory conditions, then turns those into die-cut labels and tags.
What this company is and how it runs — written from structure, not news.
Avery Dennison develops the adhesive formulations that make pressure-sensitive labels stick reliably at the speed, temperature, and surface conditions of each customer's specific filling line — then converts those formulations into finished die-cut labels built around that chemistry. Because the formulation is developed jointly with the customer's engineering team and validated over six to twelve months against FDA or food-contact standards, switching to a different supplier means restarting that entire clock from zero, and the applicator equipment on the factory floor has to be physically retuned to match the new formula's peel force. That validation record, not the label-printing equipment, is what holds the customer in place — which is why the real constraint on growth is not machine capacity but the number of technical staff who understand both adhesive chemistry and a customer's line conditions well enough to qualify a new program. If the cold-chain and high-temperature chemistries Avery Dennison currently develops in-house were to become available as standard commodity inputs from third-party suppliers, any converter could coat and cut the same label, and the lock that prevents switching would disappear with it.
How does this company make money?
The company charges per label or tag sold, priced to cover material costs plus a converting margin. On top of that, it bills customers for the custom die tools used to cut their specific label shapes, and charges technical service fees for the adhesive formulation work done to match a customer's line conditions.
What makes this company hard to replace?
Pharmaceutical and food-contact customers must run 6-to-12-month validation cycles before any new adhesive formula can touch a production line — switching suppliers means starting that clock again from zero. The label applicator machines on customer factory floors are physically calibrated to the peel force and tack of the current formula; a new supplier's formula means retuning that equipment. For customers using RFID smart labels, any new label also needs to be certified as compatible with their inventory management systems.
What limits this company?
Each label product requires its own die tool, its own adhesive formula, and its own printing plate. Switching from one product to another means physically swapping all three. So the production line's output is not capped by how fast the machines run — it is capped by how many formula-and-tooling combinations have already been tested and approved for active customers.
What does this company depend on?
The company cannot operate without acrylic and rubber-based pressure-sensitive adhesives, silicone-coated release liners, thermal transfer ribbon used in printing, precision rotary die-cutting tooling, and RFID inlays for smart label products.
Who depends on this company?
Coca-Cola and PepsiCo bottling operations would face line shutdowns if label supply were interrupted, because bottle labeling cannot continue without correctly sized and calibrated pressure-sensitive labels. Walmart and Target would lose automated price-marking on shelves, since their labeling systems require specific adhesive tack to function. Pharmaceutical companies would have to halt packaging entirely, because FDA-compliant drug labeling requires validated pressure-sensitive materials that cannot simply be swapped out.
How does this company scale?
Once a die tooling design and an adhesive formula have been developed and approved, they can be reproduced across multiple facilities to make identical labels anywhere in the world. What cannot scale as easily is the people — the technical staff who understand both adhesive chemistry and the specific conditions of a customer's filling line. Every new customer program needs those experts, and there is no shortcut to replacing them.
What external forces can significantly affect this company?
The EU Single-Use Plastics Directive restricts liner waste, which is pushing the company to develop linerless label technologies. GDPR data privacy rules are increasing demand for tamper-evident labels used in pharmaceutical track-and-trace systems. Chinese export restrictions on silicone release agents are raising the cost of liner production.
Where is this company structurally vulnerable?
If the adhesive chemistries behind cold-chain pharmaceutical and high-temperature automotive labels became widely available as standard off-the-shelf products — through Chinese chemical export expansion, open licensing, or a regulatory change that removed the need for customer-specific validation — any label converter with basic coating equipment could reproduce the formulas. The long approval cycle that keeps customers locked in would no longer belong to this company alone.
Price is read as structure — trend, levels, range, peak and volatility drawn on the chart. It does not predict where price goes next.
Sign in to view price data.
Sign in1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock behaving?
Three observations describe the present configuration: a high share of the trailing three years' weekly closes were higher than the prior week, the company has reported positive net income in each of the last five annual periods, and the book-value-increase-consistency composite over the trailing 5 years is elevated.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
What the company actually pays, and whether its own cash supports it.
The reported statements, read against the company's own industry.
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Two structural observations align: accounts receivable have increased year-over-year across the trailing four years, and receivables are a large share of current assets. Together they describe a receivables-heavy balance sheet whose receivables line keeps growing.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Companies that share the same coordination system — how they create, deliver, or capture value.
Companies that share active interpretations — structural patterns currently present in both stocks.
CompanyGraph